Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Standardized Treatment of Pulmonary Exacerbations II (STOP2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02781610
Recruitment Status : Recruiting
First Posted : May 24, 2016
Last Update Posted : June 5, 2019
Sponsor:
Collaborators:
Cystic Fibrosis Foundation
CF Therapeutics Development Network Coordinating Center
Medical University of South Carolina
University of Washington
Information provided by (Responsible Party):
Chris Goss, Seattle Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2020